GSK vs VLO · P/E 13, $103.31B cap vs P/E 18, rev $76.86B
GlaxoSmithKline PLC ADR (GSK) versus Valero Energy Corporation (VLO) — a side-by-side from cached financials, not a winner call.
GlaxoSmithKline PLC ADR (GSK) is a drug manufacturers - general company listed on US.
Valero Energy Corporation (VLO) is a oil & gas refining & marketing company listed on NYSE.
GSK does not have a complete income-statement cache yet.
Latest reported VLO revenue for 2026-06-30 was $76.86B. Net income was $4.98B. VLO currently screens at market cap $71.20B and trailing P/E 17.5.
GSK currently screens at market cap $103.31B and trailing P/E 13.5. VLO currently screens at market cap $71.20B and trailing P/E 17.5.
Not investment advice. Open the GSK and VLO stock pages for the full models.
Not investment advice.